Omada Health, Inc. OMDA
15.01 USD -0.23 (-1.54%)
Nov 12, 2026, 9:51 AM EST
14.93 Day range 15.17
10.28 52-week range 25.45
- YTD
- -4.91%
- 1 year
- -30.05%
News
seekingalpha.com Omada Health, Inc. (OMDA) Q3 2026 Earnings Call Transcript Omada Health, Inc. ( OMDA ) Q3 2026 Earnings Call November 5, 2026 4:30 PM EST Company Participants Craig Gracey - Chief Accounting Officer Sean Duffy - Co-Founder, CEO & Director Wei-Li Shao -…
fool.com Omada: 3 Key Takeaways for Long-Term Investors Third-quarter revenue grew 34% year over year to $91 million. Total membership reached 1.13 million, up 36% year over year.
schaeffersresearch.com Unusual Options Volume Report: 3 Stocks Moving After Earnings Three stocks are seeing unusual options activity following their quarterly earnings reports: DraftKings Inc (NASDAQ:DKNG), TransMedics Group Inc (NASDAQ:TMDX), and Omada Health Inc (NASDAQ:OMDA).
benzinga.com Barclays Maintains Overweight on Omada Health, Lowers Price Target to $22 Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $24 to $22.
benzinga.com Wells Fargo Maintains Equal-Weight on Omada Health, Lowers Price Target to $19 Wells Fargo analyst Stan Berenshteyn maintains Omada Health (NASDAQ:OMDA) with a Equal-Weight and lowers the price target from $22 to $19.
marketbeat.com What Omada Health (OMDA) Said on Its Q3 Earnings Call Omada Health NASDAQ: OMDA raised its full-year 2026 revenue and adjusted EBITDA outlook after reporting record quarterly revenue and net income in the third quarter, driven by enrollment and growth…
zacks.com Compared to Estimates, Omada Health, Inc. (OMDA) Q3 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for Omada Health, Inc. (OMDA) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key…
zacks.com Omada Health, Inc. (OMDA) Q3 Earnings and Revenues Beat Estimates Omada Health, Inc. (OMDA) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.02 per share a year ago.
benzinga.com Omada Health Q3 2026 Earnings Call Transcript Omada Health (NASDAQ:OMDA) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com Omada Health Raises FY2026 Sales Guidance from $334.000M-$340.000M to $344.000M-$346.000M vs $338.537M Est Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $334.000 million-$340.000 million to $344.000 million-$346.000 million vs $338.537 million estimate.
benzinga.com Omada Health Q3 EPS $0.10 Beats $0.02 Estimate, Sales $91.000M Beat $85.676M Estimate Omada Health (NASDAQ:OMDA) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.02 by 400 percent. This is a 600 percent increase over losses of $(0.02) per…
globenewswire.com Omada Health Reports Third Quarter 2026 Results Quarterly Revenue of $91 million and All-Time High Total Members of 1.1 million Revenue Grew 34% and Total Members Increased 36% Year over Year Raises Full Year 2026 Financial Outlook SAN FRANCISCO,…- benzinga.com Barclays Maintains Overweight on Omada Health, Lowers Price Target to $24 Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $27 to $24.
benzinga.com Omada Health To Present Published Research Showing That Members Of Its GLP-1 Care Track Lost More Weight And Experienced Greater Improvements In Body Composition Than GLP-1 Users Receiving Usual Care GLP-1 medications can produce rapid weight loss,2 but lean mass can account for 30% or more of the weight lost.3,4 Lean mass is critical for overall health, as losing lean mass may contribute to…
benzinga.com Transcript: Omada Health Q2 2026 Earnings Conference Call Omada Health (NASDAQ:OMDA) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by…
benzinga.com Barclays Maintains Overweight on Omada Health, Raises Price Target to $27 Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $25 to $27.
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Veeva Systems (NYSE:VEEV) shares increased by 8.7% to $266.15 during Wednesday's after-market session. The market value of their outstanding shares is at $40.0 billion. The company's, Q2…- benzinga.com JP Morgan Maintains Overweight on Omada Health, Raises Price Target to $30 JP Morgan analyst Lisa Gill maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $26 to $30.
- benzinga.com Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $32 Citizens analyst Constantine Davides maintains Omada Health (NASDAQ:OMDA) with a Market Outperform and raises the price target from $27 to $32.
- benzinga.com Baird Maintains Neutral on Omada Health, Raises Price Target to $25 Baird analyst Vikram Kesavabhotla maintains Omada Health (NASDAQ:OMDA) with a Neutral and raises the price target from $15 to $25.
benzinga.com BTIG Maintains Buy on Omada Health, Raises Price Target to $35 BTIG analyst David Larsen maintains Omada Health (NASDAQ:OMDA) with a Buy and raises the price target from $30 to $35.- benzinga.com Omada Health Raises FY2026 Sales Guidance from $322.000M-$330.000M to $334.000M-$340.000M vs $327.789M Est Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $322.000 million-$330.000 million to $334.000 million-$340.000 million vs $327.789 million estimate.
- benzinga.com Omada Health Q2 EPS $0.08 Beats $(0.01) Estimate, Sales $87.835M Beat $80.190M Estimate Omada Health (NASDAQ:OMDA) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.01) by 900 percent. This is a 133.33 percent increase over losses of $(0.24)…
- benzinga.com Barclays Maintains Overweight on Omada Health, Raises Price Target to $25 Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $20 to $25.
- benzinga.com Canaccord Genuity Maintains Buy on Omada Health, Raises Price Target to $28 Canaccord Genuity analyst Richard Close maintains Omada Health (NASDAQ:OMDA) with a Buy and raises the price target from $24 to $28.
- benzinga.com Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $27 Citizens analyst Constantine Davides maintains Omada Health (NASDAQ:OMDA) with a Market Outperform and raises the price target from $21 to $27.
benzinga.com This Moody's Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Wall Street analysts change outlook on top stocks. For detailed ratings, upgrades/downgrades, see analyst ratings page. Consider MCO stock.- benzinga.com BTIG Initiates Coverage On Omada Health with Buy Rating, Announces Price Target of $30 BTIG analyst David Larsen initiates coverage on Omada Health (NASDAQ:OMDA) with a Buy rating and announces Price Target of $30.
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Agape ATP (NASDAQ:ATPC) shares rose 17.5% to $2.96 during Wednesday's after-market session. The market value of their outstanding shares is at $2.6 million. China Pharma Holding (AMEX:CPHI)…
benzinga.com Morgan Stanley Reiterates Overweight on Omada Health, Maintains $30 Price Target Morgan Stanley analyst Craig Hettenbach reiterates Omada Health (NASDAQ:OMDA) with a Overweight and maintains $30 price target.- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session 
benzinga.com Earnings Scheduled For March 5, 2026 
benzinga.com Earnings Scheduled For November 6, 2025 - benzinga.com Earnings Scheduled For August 7, 2025
benzinga.com This Rollins Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday 
benzinga.com Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com Why Incyte Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket